SE9903995D0 - New combination - Google Patents
New combinationInfo
- Publication number
- SE9903995D0 SE9903995D0 SE9903995A SE9903995A SE9903995D0 SE 9903995 D0 SE9903995 D0 SE 9903995D0 SE 9903995 A SE9903995 A SE 9903995A SE 9903995 A SE9903995 A SE 9903995A SE 9903995 D0 SE9903995 D0 SE 9903995D0
- Authority
- SE
- Sweden
- Prior art keywords
- new combination
- active ingredient
- beta2
- beta
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9903995A SE9903995D0 (sv) | 1999-11-03 | 1999-11-03 | New combination |
| AU16526/01A AU1652601A (en) | 1999-11-03 | 2000-10-27 | New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist |
| CA002388657A CA2388657A1 (en) | 1999-11-03 | 2000-10-27 | New combination comprising a beta 2 (.beta.)2 adreno receptor agonist and a leukotriene receptor antagonist |
| EP00975117A EP1242065A1 (en) | 1999-11-03 | 2000-10-27 | New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist |
| CN00815363A CN1387431A (zh) | 1999-11-03 | 2000-10-27 | 新的包含β2肾上腺受体激动剂和白三烯受体拮抗剂的组合物 |
| PCT/SE2000/002116 WO2001032166A1 (en) | 1999-11-03 | 2000-10-27 | NEW COMBINATION COMPRISING A β2-ADRENORECEPTOR AGONIST AND A LEUKOTRIENE RECEPTOR ANTAGONIST |
| PCT/SE2000/002115 WO2001032163A1 (en) | 1999-11-03 | 2000-10-27 | NEW COMBINATION COMPRISING A BETA 2 (β)2 ADRENO RECEPTOR AGONIST AND A LENKOTRIENE RECEPTOR ANTAGONIST |
| BR0015172-6A BR0015172A (pt) | 1999-11-03 | 2000-10-27 | Nova combinação compreendendo um agonista adreno receptor de beta 2 (beta 2) e um antagonista receptor de leucotrieno |
| KR1020027005683A KR20020050254A (ko) | 1999-11-03 | 2000-10-27 | 베타 2 (β2) 아드레날린 수용체 작용제 및 류코트리엔수용체 길항제를 포함하는 신규한 조합물 |
| IL14936500A IL149365A0 (en) | 1999-11-03 | 2000-10-27 | NEW COMBINATION COMPRISING A BETA 2(β)2 ADRENO RECEPTOR AGONIST AND A LEUKOTRIENE RECEPTOR ANTAGONIST |
| MXPA02004334A MXPA02004334A (es) | 1999-11-03 | 2000-10-27 | Nueva combinacion que comprende un agonista de adrenorreceptores veta 2 y un antagonista de receptores de leucotrieno. |
| AU13214/01A AU1321401A (en) | 1999-11-03 | 2000-10-27 | New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist |
| JP2001534368A JP2003513037A (ja) | 1999-11-03 | 2000-10-27 | β2(β2)アドレノレセプターアゴニストとロイコトリエンアンタゴニストを含む新規組合せ |
| ZA200203178A ZA200203178B (en) | 1999-11-03 | 2002-04-22 | New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. |
| NO20022103A NO20022103D0 (no) | 1999-11-03 | 2002-05-02 | Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9903995A SE9903995D0 (sv) | 1999-11-03 | 1999-11-03 | New combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9903995D0 true SE9903995D0 (sv) | 1999-11-03 |
Family
ID=20417605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9903995A SE9903995D0 (sv) | 1999-11-03 | 1999-11-03 | New combination |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1242065A1 (sv) |
| JP (1) | JP2003513037A (sv) |
| KR (1) | KR20020050254A (sv) |
| CN (1) | CN1387431A (sv) |
| AU (2) | AU1321401A (sv) |
| BR (1) | BR0015172A (sv) |
| CA (1) | CA2388657A1 (sv) |
| IL (1) | IL149365A0 (sv) |
| MX (1) | MXPA02004334A (sv) |
| NO (1) | NO20022103D0 (sv) |
| SE (1) | SE9903995D0 (sv) |
| WO (2) | WO2001032166A1 (sv) |
| ZA (1) | ZA200203178B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| AR040962A1 (es) * | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
| GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| JP2007531743A (ja) * | 2004-04-05 | 2007-11-08 | セプラコア インコーポレーテッド | 他の薬剤と組合せた(r,r)−ホルモテロール |
| ES2245612B1 (es) * | 2004-06-29 | 2007-08-16 | Universidad De Barcelona | Nuevo uso terapeutico del formoterol. |
| CN101128196B (zh) * | 2005-03-16 | 2013-01-02 | Meda制药有限及两合公司 | 用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合 |
| JP2014518203A (ja) * | 2011-06-06 | 2014-07-28 | キエスィ ファルマチェウティチ エス.ピー.エー. | ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコール誘導体 |
| AR093796A1 (es) * | 2012-12-05 | 2015-06-24 | Chiesi Farm Spa | Derivados del alcohol 1-fenil-2-piridinil alquilico como inhibidores de la fosfodiesterasa |
| JP5846185B2 (ja) | 2013-11-21 | 2016-01-20 | 大日本印刷株式会社 | 貫通電極基板及び貫通電極基板を用いた半導体装置 |
| PT109030B (pt) * | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9604752D0 (sv) * | 1996-12-20 | 1996-12-20 | Astra Ab | Formulation and use |
| TR199902242T2 (xx) * | 1997-03-13 | 1999-12-21 | Merck & Co., Inc. | Kinolin l�kotrien antagonistleri. |
| SE9704644D0 (sv) * | 1997-12-12 | 1997-12-12 | Astra Ab | New use |
-
1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/sv unknown
-
2000
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/pt not_active Application Discontinuation
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en not_active Ceased
- 2000-10-27 IL IL14936500A patent/IL149365A0/xx unknown
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Ceased
- 2000-10-27 CN CN00815363A patent/CN1387431A/zh active Pending
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/es unknown
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/ko not_active Withdrawn
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/ja active Pending
-
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/xx unknown
- 2002-05-02 NO NO20022103A patent/NO20022103D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022103L (no) | 2002-05-02 |
| BR0015172A (pt) | 2002-06-18 |
| AU1321401A (en) | 2001-05-14 |
| MXPA02004334A (es) | 2002-11-07 |
| ZA200203178B (en) | 2003-07-22 |
| WO2001032166A1 (en) | 2001-05-10 |
| KR20020050254A (ko) | 2002-06-26 |
| AU1652601A (en) | 2001-05-14 |
| JP2003513037A (ja) | 2003-04-08 |
| EP1242065A1 (en) | 2002-09-25 |
| NO20022103D0 (no) | 2002-05-02 |
| CN1387431A (zh) | 2002-12-25 |
| WO2001032163A1 (en) | 2001-05-10 |
| IL149365A0 (en) | 2002-11-10 |
| CA2388657A1 (en) | 2001-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| DK1135153T3 (da) | Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| IL165279A (en) | Use of alpha-adrenergic agonists and alpha-2a antagonists for the preparation of pharmaceutical compositions for alleviating pain | |
| SE9903995D0 (sv) | New combination | |
| MXPA03000548A (es) | Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica. | |
| AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
| AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
| MXPA06002722A (es) | Composicion farmaceutica que comprende un antagonista del receptor p2x7 y un farmaco anti-inflamatorio no esteroidal. | |
| NO20020574L (no) | Substituerte 1,5-dihydropyrrol-2-on derivater som er virksomme som NMDA-reseptorantagonister for behandlingen avsmertetilstanden | |
| SE9704644D0 (sv) | New use | |
| BG105256A (en) | Muscarinic agonists and antagonists | |
| NO20004419D0 (no) | Ny anvendelse | |
| DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
| AU4179399A (en) | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders | |
| EE05211B1 (et) | Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluhirete, kohanemishirete v?i segatpi rev-depressiivsete hirete raviks v?i vltimiseks kasulike ravimite valmistamiseks | |
| HUP0002346A1 (hu) | Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény | |
| EE200100520A (et) | N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena | |
| SE0300445D0 (sv) | New combination | |
| BG106548A (en) | Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| EE200100689A (et) | IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon | |
| SE9902937D0 (sv) | Pharmaceutical compositions | |
| SE0001916D0 (sv) | Novel formulation |